Palivizumab (Synagis®) yog tshuaj tiv thaivuas tau pom tias txo qis kev mus pw hauv tsev kho mob vim muaj tus kab mob ua pa syncytial hauv qee qhov kev pheej hmoo siab cov pejxeem. Palivizumab tau tswj hwm ib hlis ib zaug rau tsib lub hlis, pib ua ntej lub caij ua pa syncytial tus kab mob txhua xyoo.
Puas yog palivizumab txhaj tshuaj tiv thaiv nyob?
Nws tsis yog tshuaj tiv thaiv tiag tiag (kev txhaj tshuaj tiv thaiv kab mob), vim nws tsis txhawb koj tus menyuam lub cev los tsim nws cov tshuaj tiv thaiv thaum lawv kis tus kabmob ntawd yav tom ntej. Nws muab li cas? Synagis yog muab raws li kev txhaj tshuaj intramuscular rau hauv cov leeg ntawm tus ncej puab.
Leej twg yuav tau txais palivizumab?
Nyob rau hauv thawj xyoo ntawm lub neej, palivizumab prophylaxis raug pom zoo rau cov menyuam mos yug ntxov ua ntej 32 lub lis piam, 0 hnub 'gestation nrog mob ntsws mob ua ntej yug me nyuam txhais tau tias xav tau ntau dua. tshaj 21% oxygen rau tsawg kawg 28 hnub tom qab yug me nyuam.
Puas Synagis tau txhaj tshuaj tiv thaiv?
Txawm li cas los xij, palivizumab (Synagis), ib qho immunoglobulin monoclonal antibody, tuaj yeem txo qhov kev pheej hmoo ntawm kev mus pw hauv tsev kho mob rau RSV. Tus qauv prophylactic koob tshuaj yog 15 mg / kg txhua 30 hnub thaum lub caij RSV, txog li tsib koob tshuaj. Palivizumab tsis cuam tshuam nrog kev txhaj tshuaj thiab tuaj yeem siv tib lub sijhawm raws li cov tshuaj tiv thaiv.
Puas yog palivizumab nyab xeeb?
Palivizumab (Synagis), humanized monoclonal IgG1 antibody rau RSV fusion protein, 3muaj pov thawj muaj kev nyab xeeb thiab siv tau 4–7 thiab tau qhia rau kev tiv thaiv tus kab mob ua pa hnyav uas tshwm sim los ntawm RSV hauv cov neeg mob menyuam yaus siab. pheej hmoo ntawm tus kab mob RSV.
